Bilcare Share News - Latest Updates, Live News & More

Latest news about Bilcare

Bilcare seeks nod for Mrs. Ashwini Ashok Hasabnis as Independent Director 2 days ago

Bilcare Limited has initiated a postal ballot for shareholder approval to appoint Mrs. Ashwini Ashok Hasabnis as a Non-Executive Woman Independent Director for a five-year term. The e-voting period runs from June 23 to July 22, 2026, with a cut-off date of June 12, 2026. The appointment requires ratification to comply with SEBI regulations.

Bilcare Ltd directed to deposit outstanding FD amounts to IEPF Jun 12, 2026

Bilcare FY26 net profit at ₹0.99 crore, loss narrows Jun 01, 2026

Bilcare board to meet on May 29 to consider Q4FY26 results May 23, 2026

Bilcare Limited Announces Director Changes and Board Committee Reconstitution Apr 25, 2026

More news about Bilcare

16Apr 26

Bilcare Limited Files SEBI Compliance Certificate for Quarter Ended March 31, 2026

Bilcare Limited submitted its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, filed through the Bombay Stock Exchange on April 16, 2026. The certificate from registrar MUFG Intime India Private Limited confirms proper processing of dematerialisation requests and adherence to prescribed timelines for securities conversion during the quarter.

31Mar 26

Bilcare Limited Board Meeting Outcome: ₹3.15 Crore Preference Share Redemption

Bilcare Limited announced completion of significant corporate actions following March 30, 2026 board meeting, including redemption of 31.50 lakh preference shares worth ₹3.15 crore from Caprihans India Limited and conversion of 12.90 lakh warrants to equity shares across multiple tranches, increasing its shareholding from 55.99% to 59.56%. The company also completed voluntary liquidation of wholly owned UK subsidiary Bilcare GCS Limited with proceeds of GBP 195,781.83 pending credit to company account.

13Feb 26

Bilcare Limited Reports Mixed Q3FY26 Results with Strong Standalone Performance Offset by Consolidated Losses

Bilcare Limited announced Q3FY26 financial results showing contrasting performance between standalone and consolidated operations. While standalone net profit grew 50.56% to ₹2.71 crores, consolidated operations reported ₹12.81 crores loss despite improvement from previous year. The company also disclosed major corporate actions involving subsidiary Caprihans India Limited including preference share redemption and convertible warrant conversion.

18Aug 25

Bilcare Limited Reports Narrowed Losses in Q1 Amid Challenging Market Conditions

Bilcare Limited's Q1 FY2024 results show a mixed performance. Consolidated total income decreased by 2.75% to ₹192.44 crores, but net loss reduced to ₹9.76 crores from ₹15.02 crores year-over-year. Standalone performance improved with profit after tax more than doubling to ₹3.59 crores. Consolidated EPS improved to ₹(1.59) from ₹(2.71) in the previous year.

21Jul 25

Bilcare Approves Voluntary Liquidation of UK Subsidiary Bilcare GCS

Bilcare Limited's Board of Directors has approved the voluntary liquidation of its wholly-owned UK subsidiary, Bilcare GCS Limited. The decision was made on July 21, 2025. Bilcare GCS contributed only 0.02% to the consolidated turnover with INR 11.88 lacs in FY 2024-25. The liquidation is not expected to significantly impact Bilcare Limited's overall financial position. The process will be carried out in accordance with UK laws, with the completion date yet to be determined.

Bilcare

56.99

+0.54

(+0.96%)

1 Year Returns:-10.53%

Industry Peers

Syngene International

436.50

(-1.18%)

Indegene

518.05

(-1.74%)

Suven Life Sciences

267.25

(+4.93%)

Vimta Labs

598.00

(+1.09%)

Take Solutions

28.02

(-3.55%)

Jeevan Scientific Technology

81.47

(-0.76%)

Bilcare

56.99

(+0.96%)

Adeshwar Meditex

13.00

(-4.06%)

Vanta Bioscience

24.09

(-4.97%)

Get More Market Insights with

Stock Rental via SLBM

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104